iShares iBonds Dec 2027 Term Corporate ETF (IBDS) |
|
23.77 0.02 (0.08%)
|
06-26 19:16 |
|
Open: |
23.77 |
Pre. Close: |
23.75 |
|
High:
|
23.85 |
Low:
|
23.73 |
|
Volume:
|
89,136 |
Market Cap:
|
0(M) |
|
|
|
|
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index is composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2027. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
23.88 - 23.97 |
23.97 - 24.06 |
|
Low:
|
23.48 - 23.6 |
23.6 - 23.71 |
|
Close:
|
23.59 - 23.76 |
23.76 - 23.93 |
|
Technical analysis |
as of: 2022-06-24 4:40:42 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 28.12 One year: 28.68 |
| Support: |
Support1: 23.3 Support2: 19.39 |
| Resistance: |
Resistance1: 24.08 Resistance2: 24.55 |
| Pivot: |
23.75  |
| Moving Average: |
MA(5): 23.68  MA(20): 23.89
MA(100): 24.65 MA(250): 25.92 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 43.6 %D(3): 36.4 |
| RSI: |
RSI(14): 43.6 |
| 52-week: |
High: 28.96 Low: 23.3 |
| Average Vol(K): |
3-Month: 186 (K) 10-Days: 125 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IBDS ] has closed below upper band by 48.2%. Bollinger Bands are 50.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue. |
|
|
Headline News |
Sat, 25 Jun 2022
Researchers Uncover Factors Associated With NAFLD in Patients With IBD - Gastroenterology & Endoscopy News
Thu, 23 Jun 2022
Does Poor Sleep Trigger IBD? - Gastroenterology & Endoscopy News
Fri, 17 Jun 2022
Understanding Cannabis as a Treatment for Ulcerative Colitis and IBD - Healthline
Thu, 09 Jun 2022
Celiac Disease and IBD Show Strong Bidirectional Link - Medscape
Wed, 08 Jun 2022
Despite Risk for Complications, Women With IBD Can Still Have a Healthy Pregnancy - Everyday Health
Wed, 08 Jun 2022
Understanding the Difference Between IBS and IBD - Orlando Health
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
